triazoles has been researched along with Drug Withdrawal Symptoms in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (18.75) | 18.7374 |
| 1990's | 8 (25.00) | 18.2507 |
| 2000's | 12 (37.50) | 29.6817 |
| 2010's | 4 (12.50) | 24.3611 |
| 2020's | 2 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Bergeria, CL; Dunn, KE; Finan, PH; Gamaldo, CE; Hammond, AS; Huhn, AS; Strain, EC; Umbricht, A | 1 |
| Hibino, H; Inoue, Y; Matsumoto, H; Mikami, A; Mikami, K; Suzuki, H | 1 |
| Campbell, EJ; Lawrence, AJ; Marchant, NJ | 1 |
| Benedict, J; Ehlers, CL; Sanchez-Alavez, M; Wills, DN | 1 |
| Engel, JA; Fredriksson, I; Jerlhag, E; Steensland, P; Suchankova, P | 1 |
| Ando, T; Kawashima, M; Koyama, K; Matsui, H; Nagai, H; Ohshima, N; Ohta, K; Sato, R; Suzuki, J; Takeda, K | 1 |
| Ninan, PT | 1 |
| Haney, M | 1 |
| Foltin, RW; Haney, M; Hart, CL; Ward, AS | 1 |
| Berrino, L; Capuano, A; De Novellis, V; Filippelli, A; Mazzeo, F; Rossi, F; Stella, L; Vitelli, MR | 1 |
| Arnow, B; Banks, P; Borian, FE; Dunner, DL; Gelenberg, AJ; Hirschfeld, RM; Howland, R; Keitner, GI; Keller, MB; Klein, DN; Kocsis, JH; Kornstein, SG; Manber, R; Markowitz, JC; Miller, I; Munsaka, M; Rothbaum, B; Rush, AJ; Russell, JM; Thase, ME; Trivedi, MH; Zajecka, J | 1 |
| Ozpoyraz, N; Tamam, L | 1 |
| Fava, M; Kelly, K; Mischoulon, D; Opitz, G; Rosenbaum, JF | 1 |
| Cory-Slechta, DA; Reeves, R; Thiruchelvam, M | 1 |
| Atack, JR; Bristow, L; Bromidge, F; Carling, R; Castro, JL; Cook, SM; Dawson, GR; Kerby, J; McKernan, RM; Melillo, D; Pike, A; Ragan, I; Sohal, B; Street, L; Sur, C; Tye, SJ; Wafford, KA; Whiting, P | 1 |
| Goodwin, GM | 1 |
| Agnati, L; Filip, M; Franco, R; Fuxe, K; Lluís, C; Marcellino, D; Navarro, G; Roberts, DC | 1 |
| Baldini, A; de Sanctis, AJ; Lisciani, R; Silvestrini, B | 1 |
| Collier, HO; Cuthbert, NJ; Francis, DL | 1 |
| Benazzi, F | 2 |
| Lauber, C | 1 |
| Markowitz, JS | 1 |
| Brewer, ER; Carson, SW; Golding, M; Kotlyar, M | 1 |
| Berkowitz, DV; Conrad, C; McDannold, M; Scharf, MB; Spinner, O; Stover, R; Zaretsky, N | 1 |
| Little, J; Rajagopalan, M | 1 |
| Diener, HC; Fritsche, G; Katsarava, Z; Limmroth, V; Muessig, M | 1 |
| Fabre, LF; Gainey, A; Kemple, S | 1 |
| Hulsman, JA; Rentmeester, TW | 1 |
| Bono, G; Mancuso, A; Mazzella, GL; Merlo, P; Sinforiani, E; Verri, AP | 1 |
| Corradi, L; Ferri, F; Fogari, R; Pasotti, C; Tettamanti, F | 1 |
| Martinelli, B; Pimpinella, G; Severini, C; Valeri, P | 1 |
2 review(s) available for triazoles and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
A sleeping giant: Suvorexant for the treatment of alcohol use disorder?
Topics: Alcoholism; Animals; Azepines; Humans; Orexin Receptor Antagonists; Sleep Wake Disorders; Substance Withdrawal Syndrome; Triazoles | 2020 |
Effects of smoked marijuana in healthy and HIV + marijuana smokers.
Topics: Bupropion; Dronabinol; Eating; HIV Seropositivity; Humans; Marijuana Smoking; Piperazines; Substance Withdrawal Syndrome; Triazoles | 2002 |
5 trial(s) available for triazoles and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Suvorexant ameliorated sleep disturbance, opioid withdrawal, and craving during a buprenorphine taper.
Topics: Analgesics, Opioid; Azepines; Buprenorphine; Craving; Double-Blind Method; Humans; Naloxone; Narcotic Antagonists; Opiate Substitution Treatment; Sleep; Substance Withdrawal Syndrome; Treatment Outcome; Triazoles | 2022 |
Nefazodone decreases anxiety during marijuana withdrawal in humans.
Topics: Adult; Affect; Antidepressive Agents, Second-Generation; Arousal; Attention; Dose-Response Relationship, Drug; Female; Humans; Male; Marijuana Abuse; Neuropsychological Tests; Piperazines; Psychomotor Performance; Sleep; Substance Withdrawal Syndrome; Triazoles | 2003 |
Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression.
Topics: Acute Disease; Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Chronic Disease; Combined Modality Therapy; Cross-Over Studies; Depressive Disorder, Major; Double-Blind Method; Eligibility Determination; Female; Humans; Male; Middle Aged; Piperazines; Psychotherapy; Recurrence; Substance Withdrawal Syndrome; Triazoles | 2003 |
Evaluation of sleep architecture and cyclic alternating pattern rates in depressed insomniac patients treated with nefazodone hydrochloride.
Topics: Adult; Antidepressive Agents, Second-Generation; Depression; Female; Humans; Male; Periodicity; Piperazines; Placebos; Polysomnography; Single-Blind Method; Sleep; Sleep Initiation and Maintenance Disorders; Sleep, REM; Substance Withdrawal Syndrome; Triazoles | 1999 |
Clinical features of withdrawal headache following overuse of triptans and other headache drugs.
Topics: Adult; Analgesics; Drug Therapy, Combination; Ergotamine; Female; Headache; Humans; Indoles; Male; Middle Aged; Oxazolidinones; Piperidines; Prospective Studies; Substance Withdrawal Syndrome; Sumatriptan; Triazoles; Tryptamines; Vasoconstrictor Agents | 2001 |
25 other study(ies) available for triazoles and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Benefits associated with switching from benzodiazepine hypnotics to suvorexant in patients with mild primary insomnia.
Topics: Adult; Azepines; Benzodiazepines; Female; Humans; Hypnotics and Sedatives; Muscle Hypotonia; Orexin Receptor Antagonists; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Treatment Outcome; Triazoles | 2017 |
Effect of suvorexant on event-related oscillations and EEG sleep in rats exposed to chronic intermittent ethanol vapor and protracted withdrawal.
Topics: Alcoholism; Animals; Azepines; Electroencephalography; Ethanol; Humans; Male; Orexin Receptor Antagonists; Rats; Rats, Wistar; Sleep Aids, Pharmaceutical; Sleep Initiation and Maintenance Disorders; Sleep Wake Disorders; Sleep, REM; Sleep, Slow-Wave; Substance Withdrawal Syndrome; Time Factors; Triazoles | 2019 |
Ghrelin receptor (GHS-R1A) antagonism suppresses both alcohol consumption and the alcohol deprivation effect in rats following long-term voluntary alcohol consumption.
Topics: Administration, Oral; Alcohol Drinking; Alcoholism; Animals; CpG Islands; DNA Methylation; Gene Expression Regulation; Ghrelin; Glycine; Male; Rats; Rats, Wistar; Receptors, Ghrelin; Self Administration; Signal Transduction; Substance Withdrawal Syndrome; Triazoles; Ventral Tegmental Area | 2013 |
Recurrence of chronic pulmonary aspergillosis after discontinuation of maintenance treatment by antifungal triazoles.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Humans; Maintenance Chemotherapy; Male; Middle Aged; Pulmonary Aspergillosis; Recurrence; Retrospective Studies; Risk Factors; Substance Withdrawal Syndrome; Triazoles | 2014 |
Pharmacokinetically induced benzodiazepine withdrawal.
Topics: Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Drug Interactions; Female; Humans; Middle Aged; Panic Disorder; Piperazines; Substance Withdrawal Syndrome; Triazoles; Venlafaxine Hydrochloride | 2001 |
Interactive role of adenosine and dopamine in the opiate withdrawal syndrome.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A2 Receptor Antagonists; Animals; Caffeine; Chromatography, High Pressure Liquid; Dopamine; Injections, Subcutaneous; Male; Microdialysis; Morphine; Pyrimidines; Rats; Rats, Wistar; Receptors, Dopamine; Substance Withdrawal Syndrome; Triazoles | 2003 |
Discontinuation symptoms associated with nefazodone.
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Piperazines; Substance Withdrawal Syndrome; Triazoles | 2003 |
A preliminary open study of the tolerability and effectiveness of nefazodone in major depressive disorder: comparing patients who recently discontinued an SSRI with those on no recent antidepressant treatment.
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Female; Humans; Male; Middle Aged; Personality Assessment; Personality Inventory; Piperazines; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Treatment Outcome; Triazoles | 2004 |
Development of behavioral sensitization to the cocaine-like fungicide triadimefon is prevented by AMPA, NMDa, DA D1 but not DA D2 receptor antagonists.
Topics: 3,4-Dihydroxyphenylacetic Acid; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Behavior, Animal; Benzazepines; Brain Chemistry; Corpus Striatum; Drug Administration Schedule; Fungicides, Industrial; Male; Mice; Mice, Inbred C57BL; Motor Activity; N-Methylaspartate; Neuronal Plasticity; Piperazines; Quinoxalines; Receptors, AMPA; Receptors, Dopamine D1; Receptors, N-Methyl-D-Aspartate; Remoxipride; Substance Withdrawal Syndrome; Time Factors; Triazoles | 2004 |
TPA023 [7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an agonist selective for alpha2- and alpha3-containing GABAA receptors, is a nonsedating anxiolytic in rodents and primates.
Topics: Acoustic Stimulation; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Animals; Anti-Anxiety Agents; Anticonvulsants; Autoradiography; Conditioning, Operant; Convulsants; Drinking; Emotions; Fear; Flumazenil; GABA Modulators; GABA-A Receptor Agonists; Humans; Male; Mice; Pentylenetetrazole; Postural Balance; Protein Binding; Pyridazines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Recombinant Proteins; Reflex, Startle; Saimiri; Substance Withdrawal Syndrome; Triazoles | 2006 |
Aromatase inhibitors and bipolar mood disorder: a case report.
Topics: Aggression; Anastrozole; Aromatase Inhibitors; Bipolar Disorder; Breast Neoplasms; Carcinoma, Lobular; Chemotherapy, Adjuvant; Combined Modality Therapy; Depressive Disorder, Major; Female; Humans; Irritable Mood; Letrozole; Middle Aged; Nitriles; Substance Withdrawal Syndrome; Triazoles | 2006 |
Increase in A2A receptors in the nucleus accumbens after extended cocaine self-administration and its disappearance after cocaine withdrawal.
Topics: Animals; Behavior, Animal; Binding, Competitive; Cocaine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Male; Nucleus Accumbens; Raclopride; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Reinforcement Schedule; Self Administration; Substance Withdrawal Syndrome; Time Factors; Triazines; Triazoles; Tritium | 2007 |
Psychopharmacological profile of dapiprazole, a new potential antipsychotic agent.
Topics: Animals; Anticonvulsants; Antipsychotic Agents; Autonomic Nervous System; Behavior, Animal; Catalepsy; Conditioning, Operant; Female; Humans; Macaca mulatta; Male; Mice; Motor Activity; Pain; Piperazines; Rabbits; Rats; Social Isolation; Stereotyped Behavior; Substance Withdrawal Syndrome; Triazoles | 1982 |
Character and meaning of quasi-morphine withdrawal phenomena elicited by methylxanthines.
Topics: 1-Methyl-3-isobutylxanthine; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Caffeine; Humans; Hypoxanthines; Morphine Dependence; Naloxone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Phosphodiesterase Inhibitors; Pyrimidines; Rats; Substance Withdrawal Syndrome; Theobromine; Theophylline; Triazoles; Xanthines | 1981 |
Dangerous interaction with nefazodone added to fluoxetine, desipramine, venlafaxine, valproate and clonazepam combination therapy.
Topics: Adult; Antidepressive Agents; Clonazepam; Cyclohexanols; Depressive Disorder; Desipramine; Drug Therapy, Combination; Female; Fluoxetine; Humans; Hypotension; Panic Disorder; Piperazines; Substance Withdrawal Syndrome; Triazoles; Venlafaxine Hydrochloride | 1997 |
Nefazodone withdrawal symptoms.
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Humans; Male; Phobic Disorders; Piperazines; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Triazoles | 1998 |
Nefazodone withdrawal syndrome.
Topics: Adult; Antidepressive Agents, Second-Generation; Female; Humans; Piperazines; Substance Withdrawal Syndrome; Triazoles | 1999 |
Re: Nefazodone withdrawal symptoms.
Topics: Antidepressive Agents, Second-Generation; Drug Interactions; Drug Therapy, Combination; Humans; Piperazines; Substance Withdrawal Syndrome; Triazoles | 1999 |
Possible nefazodone withdrawal syndrome.
Topics: Adult; Dizziness; Humans; Male; Nausea; Piperazines; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Triazoles | 1999 |
Discontinuation symptoms with nefazodone.
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Piperazines; Substance Withdrawal Syndrome; Triazoles | 1999 |
Pilot open-label study of alprazolam (U-31,889) in anxious alcoholic out-patients.
Topics: Adult; Alcoholism; Ambulatory Care; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Drug Evaluation; Female; Humans; Male; Middle Aged; Pilot Projects; Psychiatric Status Rating Scales; Substance Withdrawal Syndrome; Triazoles | 1977 |
Loreclezole monotherapy in patients with partial seizures.
Topics: Anticonvulsants; Epilepsies, Partial; Female; Humans; Male; Substance Withdrawal Syndrome; Triazoles; Valproic Acid | 1992 |
[Alcohol withdrawal syndrome. Effects of short-term treatment with dapiprazole].
Topics: Adult; Aged; Antipsychotic Agents; Drug Evaluation; Drug Tolerance; Ethanol; Humans; Male; Middle Aged; Piperazines; Substance Withdrawal Syndrome; Time Factors; Triazoles | 1988 |
[Dapiprazole in the treatment of drug withdrawal symptoms].
Topics: Adolescent; Adult; Antipsychotic Agents; Female; Heroin Dependence; Humans; Male; Piperazines; Substance Withdrawal Syndrome; Triazoles | 1988 |
Effects of dapiprazole, clonidine and yohimbine on the development of dependence and withdrawal behaviour in mice.
Topics: Animals; Behavior, Animal; Brain; Clonidine; Dose-Response Relationship, Drug; Injections, Intraventricular; Male; Mice; Mice, Inbred Strains; Morphine Dependence; Naloxone; Piperazines; Substance Withdrawal Syndrome; Triazoles; Yohimbine | 1989 |